Henry Schein Inc. (NASDAQ:HSIC) was down 7.1% on Thursday . The company traded as low as $163.27 and last traded at $166.98, with a volume of 1,069,012 shares traded. The stock had previously closed at $179.68.

A number of equities research analysts have weighed in on HSIC shares. Zacks Investment Research raised shares of Henry Schein from a “hold” rating to a “buy” rating and set a $189.00 target price on the stock in a report on Wednesday, May 4th. Vetr upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $176.75 target price on the stock in a research report on Monday, May 2nd. Credit Suisse Group AG reiterated a “hold” rating on shares of Henry Schein in a research report on Saturday, June 4th. Leerink Swann reiterated a “hold” rating on shares of Henry Schein in a research report on Thursday, May 5th. Finally, Barrington Research reiterated an “outperform” rating and set a $188.00 target price (up previously from $182.00) on shares of Henry Schein in a research report on Wednesday, May 4th. Seven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $155.37.

The company has a market capitalization of $13.70 billion and a P/E ratio of 28.57. The firm’s 50-day moving average is $177.35 and its 200-day moving average is $169.40.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.63 by $0.01. The company earned $2.87 billion during the quarter, compared to the consensus estimate of $2.85 billion. The business’s revenue was up 9.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.46 EPS. Equities research analysts forecast that Henry Schein Inc. will post $6.64 EPS for the current year.

In other Henry Schein news, EVP Gerald A. Benjamin sold 9,991 shares of the firm’s stock in a transaction on Thursday, June 2nd. The stock was sold at an average price of $175.08, for a total transaction of $1,749,224.28. Following the completion of the transaction, the executive vice president now owns 54,885 shares of the company’s stock, valued at $9,609,265.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Peter M. Mccarthy sold 1,158 shares of the firm’s stock in a transaction on Thursday, May 12th. The shares were sold at an average price of $171.75, for a total value of $198,886.50. Following the transaction, the insider now directly owns 12,285 shares of the company’s stock, valued at approximately $2,109,948.75. The disclosure for this sale can be found here.

A number of institutional investors have recently made changes to their positions in HSIC. Advantus Capital Management Inc raised its position in shares of Henry Schein by 2.8% in the fourth quarter. Advantus Capital Management Inc now owns 8,048 shares of the company’s stock valued at $1,273,000 after buying an additional 221 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Henry Schein by 18.8% in the fourth quarter. Victory Capital Management Inc. now owns 8,124 shares of the company’s stock valued at $1,285,000 after buying an additional 1,284 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. raised its position in shares of Henry Schein by 6.2% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. now owns 11,053 shares of the company’s stock valued at $1,748,000 after buying an additional 648 shares in the last quarter. Bronfman E.L. Rothschild L.P. purchased a new position in shares of Henry Schein during the fourth quarter valued at approximately $2,086,000. Finally, Utah Retirement Systems raised its position in shares of Henry Schein by 0.7% in the fourth quarter. Utah Retirement Systems now owns 15,125 shares of the company’s stock valued at $2,393,000 after buying an additional 100 shares in the last quarter.

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.